|
1
|
World Health Organization: Cardiovascular
diseases (CVDs). http://www.who.int/mediacentre/factsheets/fs317/en.
Accessed March 12, 2015.
|
|
2
|
Lusis AJ: Atherosclerosis. Nature.
407:233–241. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rosamond WD, Chambless LE, Folsom AR,
Cooper LS, Conwill DE, Clegg L, Wang CH and Heiss G: Trends in the
incidence of myocardial infarction and in mortality due to coronary
heart disease, 1987 to 1994. N Engl J Med. 339:861–867. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ross R: Atherosclerosis - an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zernecke A and Weber C: Chemokines in
atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc
Biol. 34:742–750. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Braunwald E: Shattuck lecture -
cardiovascular medicine at the turn of the millennium: triumphs,
concerns, and opportunities. N Engl J Med. 337:1360–1369. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Breslow JL: Cardiovascular disease burden
increases, NIH funding decreases. Nat Med. 3:600–601. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hansson GK and Libby P: The immune
response in atherosclerosis: a double-edged sword. Nat Rev Immunol.
6:508–519. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wildgruber M, Swirski FK and Zernecke A:
Molecular imaging of inflammation in atherosclerosis. Theranostics.
3:865–884. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stocker R and Keaney JF Jr: Role of
oxidative modifications in atherosclerosis. Physiol Rev.
84:1381–1478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Witztum JL and Steinberg D: Role of
oxidized low density lipoprotein in atherogenesis. J Clin Invest.
88:1785–1792. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Janeway CA Jr and Medzhitov R: Innate
immune recognition. Annu Rev Immunol. 20:197–216. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moore KJ, Sheedy FJ and Fisher EA:
Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol.
13:709–721. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peiser L, Mukhopadhyay S and Gordon S:
Scavenger receptors in innate immunity. Curr Opin Immunol.
14:123–128. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Park JW, Ko SH, Kim CW, Jeoung BJ and Hong
CS: Identification and characterization of the major allergen of
the Humulus japonicus pollen. Clin Exp Allergy. 29:1080–1086. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jeong KY, Han IS, Choi SY, Lee JH, Lee JS,
Hong CS and Park JW: Allergenicity of recombinant profilins from
Japanese hop, Humulus japonicus. J Investig Allergol Clin Immunol.
23:345–350. 2013.PubMed/NCBI
|
|
17
|
Park SW, Chung SK and Kim SH:
Antimutagenic effects and isolation of flavonoids from Humulus
japonicus extract. Korean Soc Food Sci Technol. 27:879–901.
1995.
|
|
18
|
Park SW, Woo CJ, Chung SK and Chung KT:
Antimicrobial and antioxidative activities of solvent fraction from
Humulus japonicus. Korean Soc Food Sci Technol. 26:464–470.
2000.
|
|
19
|
Lee YR, Kim KY, Lee SH, Kim MY, Park HJ
and Jeong HS: Antioxidant and Antitumor Activities of Methanolic
Extract form Humulus japonicus. Korean Soc Food Sci Technol.
25:357–361. 2012.
|
|
20
|
Hong MS, Son ES, Lee SJ, Lee SK, Lee YJ,
Song SD, Cho SN, Clifton E and Eum SY: Anti-mycobacterial effects
of the extract of Humulus japonicus. Korean Soc Food Sci Technol.
46:94–99. 2014. View Article : Google Scholar
|
|
21
|
Hwang SY, Jung HJ, Jang WS, Jo MJ, Kim SC
and Jee SY: Anti-inflammatory effects of the MeOH extract of
Humulus japonicus in vitro. J Korean Med Ophthalmol Otolaryngol
Dermatol. 22:71–79. 2009.In Korean.
|
|
22
|
Xia Y, Roman LJ, Masters BS and Zweier JL:
Inducible nitric-oxide synthase generates superoxide from the
reductase domain. J Biol Chem. 273:22635–22639. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Surh YJ, Chun KS, Cha HH, Han SS, Keum YS,
Park KK and Lee SS: Molecular mechanisms underlying chemopreventive
activities of anti-inflammatory phytochemicals: down-regulation of
COX-2 and iNOS through suppression of NF-kappa B activation. Mutat
Res. 480–481:243–268. 2001. View Article : Google Scholar
|
|
24
|
Park CM and Song YS: Luteolin and
luteolin-7-O-glucoside inhibit lipopolysaccharide-induced
inflammatory responses through modulation of NF-κB/AP-1/PI3K-Akt
signaling cascades in RAW 264.7 cells. Nutr Res Pract. 7:423–429.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chun SC, Jee SY, Lee SG, Park SJ, Lee JR
and Kim SC: Anti-inflammatory activity of the methanol extract of
moutan cortex in LPS-activated Raw264.7 cells. Evid Based
Complement Alternat Med. 4:327–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kubes P and McCafferty DM: Nitric oxide
and intestinal inflammation. Am J Med. 109:150–158. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Watson WH, Zhao Y and Chawla RK:
S-adenosylmethionine attenuates the lipopolysaccharide-induced
expression of the gene for tumour necrosis factor alpha. Biochem J.
342:21–25. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Adams DO and Hamilton TA: The cell biology
of macrophage activation. Annu Rev Immunol. 2:283–318. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Moncada S, Palmer RM and Higgs EA: Nitric
oxide: physiology, pathophysiology, and pharmacology. Pharmacol
Rev. 43:109–142. 1991.PubMed/NCBI
|
|
30
|
Wink DA, Vodovotz Y, Laval J, Laval F,
Dewhirst MW and Mitchell JB: The multifaceted roles of nitric oxide
in cancer. Carcinogenesis. 19:711–721. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim ND, Kim EM, Kang KW, Cho MK, Choi SY
and Kim SG: Ginsenoside Rg3 inhibits phenylephrine-induced vascular
contraction through induction of nitric oxide synthase. Br J
Pharmacol. 140:661–670. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vane JR, Bakhle YS and Botting RM:
Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 38:97–120.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Collins RG, Velji R, Guevara NV, Hicks MJ,
Chan L and Beaudet AL: P-Selectin or intercellular adhesion
molecule (ICAM)-1 deficiency substantially protects against
atherosclerosis in apolipoprotein E-deficient mice. J Exp Med.
191:189–194. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cybulsky MI and Gimbrone MA Jr:
Endothelial expression of a mononuclear leukocyte adhesion molecule
during atherogenesis. Science. 251:788–791. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Braunersreuther V and Mach F: Leukocyte
recruitment in atherosclerosis: potential targets for therapeutic
approaches? Cell Mol Life Sci. 63:2079–2088. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huo Y and Ley K: Adhesion molecules and
atherogenesis. Acta Physiol Scand. 173:35–43. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Broide DH, Humber D, Sullivan S and
Sriramarao P: Inhibition of eosinophil rolling and recruitment in
P-selectin- and intracellular adhesion molecule-1-deficient mice.
Blood. 91:2847–2856. 1998.PubMed/NCBI
|
|
38
|
Kuhlman P, Moy VT, Lollo BA and Brian AA:
The accessory function of murine intercellular adhesion molecule-1
in T lymphocyte activation. Contributions of adhesion and
co-activation. J Immunol. 146:1773–1782. 1991.PubMed/NCBI
|
|
39
|
Parhami F, Fang ZT, Fogelman AM, Andalibi
A, Territo MC and Berliner JA: Minimally modified low density
lipoprotein-induced inflammatory responses in endothelial cells are
mediated by cyclic adenosine monophosphate. J Clin Invest.
92:471–478. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Nagarajan S, Burris RL, Stewart BW,
Wilkerson JE and Badger TM: Dietary soy protein isolate ameliorates
atherosclerotic lesions in apolipoprotein E-deficient mice
potentially by inhibiting monocyte chemoattractant protein-1
expression. J Nutr. 138:332–337. 2008.PubMed/NCBI
|
|
41
|
Gu L, Okada Y, Clinton SK, Gerard C,
Sukhova GK, Libby P and Rollins BJ: Absence of monocyte
chemoattractant protein-1 reduces atherosclerosis in low density
lipoprotein receptor-deficient mice. Mol Cell. 2:275–281. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bourdillon MC, Poston RN, Covacho C,
Chignier E, Bricca G and McGregor JL: ICAM-1 deficiency reduces
atherosclerotic lesions in double-knockout mice
(ApoE(−/−)/ICAM-1(−/−)) fed a fat or a chow
diet. Arterioscler Thromb Vasc Biol. 20:2630–2635. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Medbury HJ, James V, Ngo J, Hitos K, Wang
Y, Harris DC and Fletcher JP: Differing association of macrophage
subsets with atherosclerotic plaque stability. Int Angiol.
32:74–84. 2013.PubMed/NCBI
|
|
44
|
Medbury HJ, Tarran SL, Guiffre AK,
Williams MM, Lam TH, Vicaretti M and Fletcher JP: Monocytes
contribute to the atherosclerotic cap by transformation into
fibrocytes. Int Angiol. 27:114–123. 2008.PubMed/NCBI
|
|
45
|
Ren S, Fan X, Peng L, Pan L, Yu C, Tong J,
Zhang W and Liu P: Expression of NF-κB, CD68 and CD105 in carotid
atherosclerotic plaque. J Thorac Dis. 5:771–776. 2013.
|
|
46
|
Ghayur T, Banerjee S, Hugunin M, Butler D,
Herzog L, Carter A, Quintal L, Sekut L, Talanian R, Paskind M, et
al: Caspase-1 processes IFN-gamma-inducing factor and regulates
LPS-induced IFN-gamma production. Nature. 386:619–623. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K,
Fleming MA, Hayashi N, Higashino K, Okamura H, Nakanishi K, et al:
Activation of interferon-gamma inducing factor mediated by
interleukin-1beta converting enzyme. Science. 275:206–209. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Seta Y, Kanda T, Tanaka T, Arai M,
Sekiguchi K, Yokoyama T, Kurimoto M, Tamura J and Kurabayashi M:
Interleukin 18 in acute myocardial infarction. Heart. 84:668–669.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mallat Z, Corbaz A, Scoazec A, Besnard S,
Lesèche G, Chvatchko Y and Tedgui A: Expression of interleukin-18
in human atherosclerotic plaques and relation to plaque
instability. Circulation. 104:1598–1603. 2001. View Article : Google Scholar : PubMed/NCBI
|
